News

DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions

Topics: Controlled substances and Dea

Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.

Read More →

Nominations for 2014 NABP Annual Awards Now Being Accepted

NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.

Read More →

Deceptive Practices By Illegal Online Drug Sellers Give Consumers a False Sense of Legitimacy and Safety, Reports NABP

Topics: Counterfeit drugs and Buying medicine online

The National Association of Boards of Pharmacy® (NABP®) today issued a report emphasizing the deceptive practices that illegal online drug sellers use to make consumers believe that they are legitimate, safe, and trustworthy. 

Read More →

Proposed Law Calls for Commission to Focus on Prescription Drug Abuse Efforts

Topics: Prescription drug abuse

A bill calling for a 30-member commission to coordinate law enforcement and health agency efforts to combat prescription drug abuse was introduced to the United States Senate. 

Read More →

Five Individuals Charged With Diversion of Prescription Controlled Substances

Topics: Diversion and Dea

Five individuals have been indicted and arrested on charges related to their involvement in a prescription drug diversion scheme. 

Read More →

Montana Man Sentenced for Role in Distribution of Fake Cancer Drugs

Topics: Counterfeit drugs

Paul Bottomley of Montana forfeited nearly $6 million in cash and property and was sentenced to five years probation for his role in the scheme that imported fake cancer drugs into US clinics, ultimately reaching patients.

Read More →

FDA Raises Awareness About Safe Use of Acetaminophen

Topics: Over the counter

FDA is alerting consumers to be mindful of the amount of acetaminophen they take in order to prevent overdose and potential liver damage. 

Read More →

NABP Delivers Testimony at House Subcommittee Hearing on Reforming Compounding Regulations

Topics: Compounding

A United States House of Representatives subcommittee held a hearing July 16, 2013, to examine various bills aimed to implement new frameworks for the regulation of compounding. 

Read More →

Attorneys General in Nebraska and Oklahoma Call On Google to Remove 'No Prescription Required' Ads from YouTube

Topics: Counterfeit drugs and Buying medicine online

Attorneys General are calling on Google to remove video ads from YouTube that promote rogue Internet sites marketing medications, including controlled substances, as “no prescription required” products.

Read More →

Massachusetts House Considers Compounding Bill

Topics: Compounding

Legislation intended to help ensure the safety of drugs compounded in Massachusetts is being considered by the state’s House of Representatives. 

Read More →

NABPLAW Online Now Supports Mobile Devices

Topics: Pharmacists

In 2013, NABP is celebrating the 20th anniversary of NABPLAW® Online, the comprehensive national data bank of state pharmacy laws and regulations provided by NABP.

Read More →

August DEA Conferences on Preventing Drug Diversion Open to Pharmacy Personnel in California

Topics: Diversion and Dea

Drug Enforcement Administration (DEA) is offering Pharmacy Diversion Awareness Conferences (PDACs) in both southern and northern California. 

Read More →

State and Federal Regulators Continue to Combat Rogue Internet Drug Sellers, US GAO Reports

Topics: Buying medicine online

While facing the challenges of investigating and prosecuting complex, global operations, federal agencies in the United States continue to take action against Web sites illegally distributing prescription drugs to US consumers.

Read More →

Distribution of Counterfeit Drugs to US Residents Via Rogue Internet Sites Continues to Grow, Reports CNN

Topics: Counterfeit drugs

The problem of counterfeit drugs distributed into the US via rogue Internet drug sellers is growing, FDA consumer safety officers told CNN’s Sanjay Gupta, MD, as part of a special report.

Read More →

More Women Dying of Prescription Painkiller Overdoses

Topics: Prescription drug abuse

Every day, approximately 18 women die from an overdose of prescription pain medication, reports the Centers for Disease Control and Prevention (CDC).

Read More →

DEA to Hold Next Prescription Drug Take-Back Day on October 26, 2013

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) will provide another opportunity for consumers to dispose of unneeded and expired prescription drugs during the 7th DEA National Prescription Drug Take-Back Day, October 26, 2013.

Read More →

Maine Law to Allow Importation of Prescription Drugs for Personal Uses

Topics: Patient safety

A new law in Maine will allow residents to import prescription drugs for personal use from mail order pharmacies located in Australia, Canada, New Zealand, and the United Kingdom.

Read More →

Kansas Launches Pilot of New NABP PMP Software

Topics: Prescription monitoring program

At the request of several prescription monitoring program (PMP) administrators, NABP is working on building PMP software that will work seamlessly with NABP PMP InterConnect® as well as meet the needs of administrators, requestors, and data submitters with more options and flexibility. 

Read More →

FDA Provides New Resources on Importance of Safe Storage and Disposal of Fentanyl Patches

Topics: Medication errors

As part of its efforts to prevent accidental exposure to fentanyl patches, FDA is providing new resources about safe storage and safe disposal of the patches.

Read More →

Thousands of Rogue Online Drug Sellers Shut Down During Operation Pangea VI

Topics: Counterfeit drugs and Buying medicine online

As part of the sixth annual International Internet Week of Action (IIWA), Food and Drug Administration (FDA) took action against more than 9,600 Web sites illegally selling drugs that included counterfeit, substandard, and other potentially dangerous products. 

Read More →

August DEA Conference on Preventing Drug Diversion Open to Pharmacy Personnel in Louisiana

Topics: Diversion and Pharmacists

DEA is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDAC) in Baton Rouge, LA.

Read More →

Consent Decree Prohibits New Jersey Pharmacy from Manufacturing, Distributing Drug Products

Topics: Compounding

Med Prep Consulting, Inc, has been prohibited from manufacturing, holding, and distributing drug products under a consent decree of permanent injunction entered against the pharmacy by a federal court. 

Read More →

AMA Policy Deems 'Inappropriate Queries' From Pharmacies an Interference With Practice of Medicine

Topics: Pharmacies, Pharmacists, and Prescription drug abuse

The American Medical Association (AMA) has adopted a resolution stating that the organization deems certain pharmacy inquiries relating to the verification of prescriptions to be “an interference with the practice of medicine and unwarranted.” 

Read More →